English
Aarti Pharmalabs Q3 Results
- BSE: 543748
- NSE: AARTIPHARM
- ISIN: INE0LRU01027
- Sector: Biotechnology & Drugs
BSE
803.85
10.80 (1.36%)
10.80 (1.36%)Volume9.71 K
Updated: Fri 16 Jan, 2026 | 15:44:06
NSE
802.9511.10 (1.40%)
11.10 (1.40%)Volume2.89 L
Updated: Fri 16 Jan, 2026 | 15:44:21
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Quarter ended Dec 24
Note: Comparison is on QoQ basis
Quarterly - Aarti Pharmalabs Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 24 | Sep 24 | QoQ Comp | Dec 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 432.21 | 385.24 | 12.19% | 371.78 | 16.25% |
| Depreciation/ Amortization | 23.04 | 20.88 | 10.32% | 18.77 | 22.74% |
| Operating Income | 105.57 | 72.79 | 45.04% | 76.91 | 37.27% |
| Net Income | 73.99 | 54.62 | 35.45% | 52.76 | 40.24% |
| Other Operating Expenses Total | 92.23 | 91.05 | 1.30% | 72.42 | 27.35% |
| Net Income Before Taxes | 100.63 | 71.77 | 40.21% | 73.82 | 36.31% |
| Total Revenue | 537.78 | 458.03 | 17.41% | 448.69 | 19.86% |
| Selling/ General/ Admin Expenses Total | 41.63 | 37.73 | 10.34% | 36.16 | 15.13% |
| Diluted Normalized EPS | 8.16 | 6.02 | 35.55% | 5.82 | 40.21% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.